Dr. Verena Boder

Dr. Verena Boder has over 21 years of experience in General Medicine, Endocrinology, and Diabetology. She currently serves as a Senior Consultant at Güssing General Hospital, specializing in the diagnosis and management of endocrine disorders, particularly diabetes and thyroid diseases. Dr. Boder started her career at the Medical University of Vienna, where she completed her medical training and residency in endocrinology. Over the years, she has built a strong reputation for her expertise in treating type 2 diabetes, hypothyroidism, and metabolic disorders, providing patients with comprehensive management plans that combine lifestyle changes, medications, and regular monitoring.

Dr. Boder has conducted significant research in the fields of endocrinology and diabetes management, with a focus on early diagnosis and personalized treatment for type 2 diabetes. Her research has focused on the relationship between obesity and insulin resistance, and how these factors contribute to the development of diabetes and cardiovascular diseases. She has published numerous articles in reputable journals such as The European Journal of Endocrinology and Diabetes Care. Additionally, Dr. Boder has been part of several clinical trials examining the efficacy of new diabetic medications and treatments for thyroid diseases.

• Best Endocrinologist of the Year – Güssing General Hospital, 2020

• Outstanding Researcher in Diabetes Care – Medical University of Vienna, 2017

• Excellence in Thyroid Disease Management – Austrian Society of Endocrinology, 2019

Dr. Verena Boder has authored a wide range of studies in the field of diabetes and endocrine disorders. Her research on insulin resistance and metabolic syndrome has been published in The Journal of Clinical Endocrinology & Metabolism. She also co-authored studies on diabetic neuropathy and thyroid disease management, which were featured in The European Thyroid Journal. Her work has had a lasting impact on both clinical practices and research in endocrinology, particularly in the development of more effective treatment protocols for diabetes and thyroid disorders.